LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Inicio・Lista de Acciones・Veracyte Inc

Veracyte Inc

Cerrado

SectorSanidad

45 -0.2

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

44.65

Máximo

45.81

Métricas clave
By Trading Economics
Ingresos	-20M 29M
Ventas	-1.6M 139M
P/B Media del Sector	38.426 49.701
BPA	0.52
Margen de beneficios	20.642
Empleados	755
EBITDA	-17M 29M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+0.2% upside

Dividendos
By Dow Jones
Próximas Ganancias	5 ago 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	642M 3.3B
Apertura anterior	45.2
Cierre anterior	45

Puntuación técnica

By Trading Central

Confianza

Weak Bearish Evidence

30.5 / 31.38 Soporte y Resistencia

Veracyte Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

22 may 2026, 16:33 UTC

Ganancias

Principales Movimientos del Mercado

Webull Shares Slide on 1Q Loss, Soaring Costs

22 may 2026, 21:10 UTC

Ganancias

These Stocks Are Today's Movers: Dell, Apple, IBM, Estée Lauder, Futu, Rocket Lab, Workday, and More -- Barrons.com

22 may 2026, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

22 may 2026, 20:50 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Financial Services Roundup: Market Talk

22 may 2026, 20:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

22 may 2026, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

22 may 2026, 19:47 UTC

Ganancias

Nvidia Has a Plan to Get the Stock Moving Again -- Barrons.com

22 may 2026, 19:17 UTC

Charlas de Mercado

U.S. Natural Gas Retreats As Weather Outlook Cools -- Market Talk

22 may 2026, 19:10 UTC

Charlas de Mercado

Oil Futures Edge Up Ahead of U.S. Long Weekend -- Market Talk

22 may 2026, 18:54 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

22 may 2026, 18:54 UTC

Charlas de Mercado

Kroger Seen Narrowing Pricing Gap Versus Walmart -- Market Talk

22 may 2026, 18:38 UTC

Charlas de Mercado

Canada's Population Slowdown Hits Demand for Consumer Companies -- Market Talk

22 may 2026, 18:35 UTC

Adquisiciones, fusiones, absorciones

IMAX Might Be Exploring a Sale. Who Could Be Buying. -- Barrons.com

22 may 2026, 18:09 UTC

Charlas de Mercado

Centralized Crypto Lending Slows in 1Q -- Market Talk

22 may 2026, 17:58 UTC

Charlas de Mercado

U.S. Oil Rig Count Shows Signs of Picking Up -- Market Talk

22 may 2026, 17:54 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

22 may 2026, 17:54 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

22 may 2026, 17:54 UTC

Charlas de Mercado

Canada Minister May Be Distancing From Online-Streaming Order -- Market Talk

22 may 2026, 17:03 UTC

Charlas de Mercado

Canada Spending Obligations on Streamers Is More Severe Beneath Surface -- Market Talk

22 may 2026, 16:54 UTC

Charlas de Mercado

Crypto Spot Volumes Fall 14% in April -- Market Talk

22 may 2026, 16:20 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Financial Services Roundup: Market Talk

22 may 2026, 16:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

22 may 2026, 16:20 UTC

Charlas de Mercado

Energy & Utilities Roundup: Market Talk

22 may 2026, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

22 may 2026, 16:16 UTC

Charlas de Mercado

TSX Growth Driven Almost Entirely by Materials Sector -- Market Talk

22 may 2026, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

22 may 2026, 15:55 UTC

Charlas de Mercado

Trump Admin Grants Reinforce IBM's Quantum Computing Leadership -- Market Talk

22 may 2026, 15:42 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

22 may 2026, 15:42 UTC

Charlas de Mercado

Oil Continues as Leading Indicator for All Markets -- Market Talk

22 may 2026, 15:35 UTC

Charlas de Mercado

Gas Prices May Limit Spread of Inflationary Pressures in Canada -- Market Talk

Comparación entre iguales

Cambio de precio

Veracyte Inc previsión

Precio Objetivo

By TipRanks

0.2% repunte

Estimación a 12 Meses

Media 45.28 USD 0.2%

Máximo 52 USD

Mínimo 39.7 USD

De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Veracyte Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

8 ratings

Comprar

Mantener

Vender

De acuerdo con 8 analistas que ofrecen calificaciones bursátiles a para Veracyte Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

30.5 / 31.38Soporte y Resistencia

Recent bearish events outweigh bullish events.

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Veracyte Inc

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; and Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis. It is also developing Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.